News

Video

Overview on Advanced RCC: Epidemiology, Presentation, and Risk Stratification

Author(s):

Ulka Vaishampayan, MDLaurence Albiges, MD, PhD

Explore statistics behind and possible patient presentations of advanced renal cell carcinoma (RCC), with insight into IMDC risk stratification that may influence treatment strategies and outcomes.

Related Videos
Hope Rugo, MD, FASCO, and Aditya Bardia, MD, MPH, FASCO
Hope Rugo, MD, FASCO, and Aditya Bardia, MD, MPH, FASCO
Guillermo Garcia-Manero, MD
Toni Choueiri, MD, director, Lank Center for Genitourinary Oncology, co-leader, kidney cancer program, Dana-Farber Cancer Institute; Jerome and Nancy Kohlberg Chair, professor, medicine, Harvard Medical School
Eric Jonasch, MD, professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Robert Z. Orlowski, MD, PhD, and Jonathan Kaufman, MD
Robert Z. Orlowski, MD, PhD, and Jonathan Kaufman, MD
Hope Rugo, MD, FASCO, and Aditya Bardia, MD, MPH, FASCO
Hope Rugo, MD, FASCO, and Aditya Bardia, MD, MPH, FASCO
David A. Braun, MD, PhD
Related Content
Renal Cell Carcinoma | Image Credit: © Crystal light - stock.adobe.com
September 17th 2024

Ipilimumab Plus Nivolumab Increases 12-Month OS Rate vs SOC in nccRCC

Guillermo Garcia-Manero, MD, professor, chief, section of Myelodysplastic Syndromes, deputy chair, Translational Research, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
August 19th 2024

Garcia-Manero on MDS Treatment Updates With Luspatercept and Beyond

Toni Choueiri, MD, of Dana-Farber Cancer Institute
September 13th 2024

Tivozanib Monotherapy Bests Lower-Dose Tivozanib Plus Nivolumab in Metastatic RCC

Shannon N. Westin, MD, MPH, FACOG, professor, clinical medical director, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center
August 15th 2024

FDA Approval Insights: Durvalumab/Chemotherapy in dMMR Advanced Endometrial Cancer

Alana Welm, PhD
September 13th 2024

Researchers Develop Mechanism that Predicts Severity of Aggressive Form of Breast Cancer

Adam E. Singer, MD, PhD, of UCLA Health
September 13th 2024

Cabozantinib/Nivolumab Combination Findings Further Inform RCC Care